 | • レポートコード：MRC2012A0737 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫・炎症性免疫調節剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫・炎症性免疫調節剤の種類別市場規模（生物製剤、小分子）、用途別市場規模（関節リウマチ、IBD）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Biogen Idec、F. Hoffmann-La Roche、Johnson & Johnson、Avaxia Biologics、Amgen、Boehringer Ingelheim、AstraZeneca、Pfizer、Bristol-Myers Squibb、Eli Lilly、Enlivex Therapeutics、Gilead Sciences、 ・地域別グローバル市場分析 2015年-2020年 ・自己免疫・炎症性免疫調節剤の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫・炎症性免疫調節剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫・炎症性免疫調節剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫・炎症性免疫調節剤の南米市場（ブラジル、アルゼンチン） ・自己免疫・炎症性免疫調節剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生物製剤、小分子 ・用途別分析：関節リウマチ、IBD ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Autoimmune and Inflammatory Immunomodulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Autoimmune and Inflammatory Immunomodulators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Autoimmune and Inflammatory Immunomodulators market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune and Inflammatory Immunomodulators market has been segmented into
Biologics
Small molecules
By Application, Autoimmune and Inflammatory Immunomodulators has been segmented into:
Rheumatoid arthritis
IBD
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune and Inflammatory Immunomodulators market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune and Inflammatory Immunomodulators markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune and Inflammatory Immunomodulators market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune and Inflammatory Immunomodulators market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune and Inflammatory Immunomodulators Market Share Analysis
Autoimmune and Inflammatory Immunomodulators competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune and Inflammatory Immunomodulators sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune and Inflammatory Immunomodulators sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune and Inflammatory Immunomodulators are:
AbbVie
Biogen Idec
F. Hoffmann-La Roche
Johnson & Johnson
Avaxia Biologics
Amgen
Boehringer Ingelheim
AstraZeneca
Pfizer
Bristol-Myers Squibb
Eli Lilly
Enlivex Therapeutics
Gilead Sciences
Among other players domestic and global, Autoimmune and Inflammatory Immunomodulators market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Autoimmune and Inflammatory Immunomodulators product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Autoimmune and Inflammatory Immunomodulators, with price, sales, revenue and global market share of Autoimmune and Inflammatory Immunomodulators in 2018 and 2019.
Chapter 3, the Autoimmune and Inflammatory Immunomodulators competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Autoimmune and Inflammatory Immunomodulators breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Autoimmune and Inflammatory Immunomodulators market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Autoimmune and Inflammatory Immunomodulators sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Autoimmune and Inflammatory Immunomodulators Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Autoimmune and Inflammatory Immunomodulators Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Biologics
1.2.3 Small molecules
1.3 Market Analysis by Application
1.3.1 Overview: Global Autoimmune and Inflammatory Immunomodulators Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid arthritis
1.3.3 IBD
1.4 Overview of Global Autoimmune and Inflammatory Immunomodulators Market
1.4.1 Global Autoimmune and Inflammatory Immunomodulators Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen Idec
2.2.1 Biogen Idec Details
2.2.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen Idec SWOT Analysis
2.2.4 Biogen Idec Product and Services
2.2.5 Biogen Idec Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche SWOT Analysis
2.3.4 F. Hoffmann-La Roche Product and Services
2.3.5 F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Avaxia Biologics
2.5.1 Avaxia Biologics Details
2.5.2 Avaxia Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Avaxia Biologics SWOT Analysis
2.5.4 Avaxia Biologics Product and Services
2.5.5 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Boehringer Ingelheim
2.7.1 Boehringer Ingelheim Details
2.7.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Boehringer Ingelheim SWOT Analysis
2.7.4 Boehringer Ingelheim Product and Services
2.7.5 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Eli Lilly SWOT Analysis
2.11.4 Eli Lilly Product and Services
2.11.5 Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Enlivex Therapeutics
2.12.1 Enlivex Therapeutics Details
2.12.2 Enlivex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Enlivex Therapeutics SWOT Analysis
2.12.4 Enlivex Therapeutics Product and Services
2.12.5 Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Gilead Sciences
2.13.1 Gilead Sciences Details
2.13.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Gilead Sciences SWOT Analysis
2.13.4 Gilead Sciences Product and Services
2.13.5 Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Autoimmune and Inflammatory Immunomodulators Manufacturer Market Share in 2019
3.3.2 Top 6 Autoimmune and Inflammatory Immunomodulators Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Regions
4.1.1 Global Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Regions (2015-2020)
4.1.2 Global Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Regions (2015-2020)
4.2 North America Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
4.3 Europe Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
4.5 South America Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Country
5.1.1 North America Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Country (2015-2020)
5.1.2 North America Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Country (2015-2020)
5.2 United States Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
5.3 Canada Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
5.4 Mexico Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Country
6.1.1 Europe Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Country (2015-2020)
6.1.2 Europe Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Country (2015-2020)
6.2 Germany Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
6.3 UK Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
6.4 France Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
6.5 Russia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
6.6 Italy Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Regions (2015-2020)
7.2 China Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7.3 Japan Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7.4 Korea Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7.5 India Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
7.7 Australia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Country
8.1.1 South America Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Country (2015-2020)
8.1.2 South America Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Country (2015-2020)
8.2 Brazil Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
8.3 Argentina Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
9.3 Turkey Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
9.4 Egypt Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
9.5 South Africa Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Autoimmune and Inflammatory Immunomodulators Sales and Market Share by Type (2015-2020)
10.2 Global Autoimmune and Inflammatory Immunomodulators Revenue and Market Share by Type (2015-2020)
10.3 Global Autoimmune and Inflammatory Immunomodulators Price by Type (2015-2020)
11 Global Autoimmune and Inflammatory Immunomodulators Market Segment by Application
11.1 Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application (2015-2020)
11.2 Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Application (2015-2020)
11.3 Global Autoimmune and Inflammatory Immunomodulators Price by Application (2015-2020)
12 Market Forecast
12.1 Global Autoimmune and Inflammatory Immunomodulators Sales, Revenue and Growth Rate (2021-2025)
12.2 Autoimmune and Inflammatory Immunomodulators Market Forecast by Regions (2021-2025)
12.2.1 North America Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025)
12.2.2 Europe Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025)
12.2.3 Asia-Pacific Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025)
12.2.4 South America Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025)
12.2.5 Middle East & Africa Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025)
12.3 Autoimmune and Inflammatory Immunomodulators Market Forecast by Type (2021-2025)
12.3.1 Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Type (2021-2025)
12.3.2 Global Autoimmune and Inflammatory Immunomodulators Market Share Forecast by Type (2021-2025)
12.4 Autoimmune and Inflammatory Immunomodulators Market Forecast by Application (2021-2025)
12.4.1 Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Application (2021-2025)
12.4.2 Global Autoimmune and Inflammatory Immunomodulators Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Autoimmune and Inflammatory Immunomodulators Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune and Inflammatory Immunomodulators by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune and Inflammatory Immunomodulators Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Autoimmune and Inflammatory Immunomodulators Major Business
Table 9. AbbVie Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Autoimmune and Inflammatory Immunomodulators Product and Services
Table 12. AbbVie Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 14. Biogen Idec Autoimmune and Inflammatory Immunomodulators Major Business
Table 15. Biogen Idec Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 16. Biogen Idec SWOT Analysis
Table 17. Biogen Idec Autoimmune and Inflammatory Immunomodulators Product and Services
Table 18. Biogen Idec Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 20. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Major Business
Table 21. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 22. F. Hoffmann-La Roche SWOT Analysis
Table 23. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Product and Services
Table 24. F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Major Business
Table 27. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Product and Services
Table 30. Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Avaxia Biologics Basic Information, Manufacturing Base and Competitors
Table 32. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Major Business
Table 33. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 34. Avaxia Biologics SWOT Analysis
Table 35. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Product and Services
Table 36. Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Amgen Basic Information, Manufacturing Base and Competitors
Table 38. Amgen Autoimmune and Inflammatory Immunomodulators Major Business
Table 39. Amgen Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 40. Amgen SWOT Analysis
Table 41. Amgen Autoimmune and Inflammatory Immunomodulators Product and Services
Table 42. Amgen Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 44. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Major Business
Table 45. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 46. Boehringer Ingelheim SWOT Analysis
Table 47. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Product and Services
Table 48. Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca Autoimmune and Inflammatory Immunomodulators Major Business
Table 51. AstraZeneca Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca SWOT Analysis
Table 53. AstraZeneca Autoimmune and Inflammatory Immunomodulators Product and Services
Table 54. AstraZeneca Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Autoimmune and Inflammatory Immunomodulators Major Business
Table 57. Pfizer Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Autoimmune and Inflammatory Immunomodulators Product and Services
Table 60. Pfizer Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 62. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Major Business
Table 63. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 64. Bristol-Myers Squibb SWOT Analysis
Table 65. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Product and Services
Table 66. Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Eli Lilly Autoimmune and Inflammatory Immunomodulators Major Business
Table 69. Eli Lilly Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 70. Eli Lilly SWOT Analysis
Table 71. Eli Lilly Autoimmune and Inflammatory Immunomodulators Product and Services
Table 72. Eli Lilly Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Enlivex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Major Business
Table 75. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 76. Enlivex Therapeutics SWOT Analysis
Table 77. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Product and Services
Table 78. Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 80. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Major Business
Table 81. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Total Revenue (USD Million) (2017-2018)
Table 82. Gilead Sciences SWOT Analysis
Table 83. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Product and Services
Table 84. Gilead Sciences Autoimmune and Inflammatory Immunomodulators Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Autoimmune and Inflammatory Immunomodulators Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global Autoimmune and Inflammatory Immunomodulators Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Autoimmune and Inflammatory Immunomodulators Sales by Regions (2015-2020) (K Units)
Table 88. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Regions (2015-2020)
Table 89. Global Autoimmune and Inflammatory Immunomodulators Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Autoimmune and Inflammatory Immunomodulators Sales by Countries (2015-2020) (K Units)
Table 91. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries (2015-2020)
Table 92. North America Autoimmune and Inflammatory Immunomodulators Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020)
Table 94. Europe Autoimmune and Inflammatory Immunomodulators Sales by Countries (2015-2020) (K Units)
Table 95. Europe Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries (2015-2020)
Table 96. Europe Autoimmune and Inflammatory Immunomodulators Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Autoimmune and Inflammatory Immunomodulators Sales by Countries (2015-2020) (K Units)
Table 101. South America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries (2015-2020)
Table 102. South America Autoimmune and Inflammatory Immunomodulators Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Autoimmune and Inflammatory Immunomodulators Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Autoimmune and Inflammatory Immunomodulators Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020)
Table 108. Global Autoimmune and Inflammatory Immunomodulators Sales by Type (2015-2020) (K Units)
Table 109. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Type (2015-2020)
Table 110. Global Autoimmune and Inflammatory Immunomodulators Revenue by Type (2015-2020) (USD Million)
Table 111. Global Autoimmune and Inflammatory Immunomodulators Revenue Share by Type (2015-2020)
Table 112. Global Autoimmune and Inflammatory Immunomodulators Sales by Application (2015-2020) (K Units)
Table 113. Global Autoimmune and Inflammatory Immunomodulators Sales Share by Application (2015-2020)
Table 114. Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global Autoimmune and Inflammatory Immunomodulators Market Share Forecast by Regions (2021-2025)
Table 116. Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global Autoimmune and Inflammatory Immunomodulators Market Share Forecast by Type (2021-2025)
Table 118. Global Autoimmune and Inflammatory Immunomodulators Sales Forecast by Application (2021-2025)
Table 119. Global Autoimmune and Inflammatory Immunomodulators Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Autoimmune and Inflammatory Immunomodulators Picture
Figure 2. Global Sales Market Share of Autoimmune and Inflammatory Immunomodulators by Type in 2019
Figure 3. Biologics Picture
Figure 4. Small molecules Picture
Figure 5. Autoimmune and Inflammatory Immunomodulators Sales Market Share by Application in 2018
Figure 6. Rheumatoid arthritis Picture
Figure 7. IBD Picture
Figure 8. Global Autoimmune and Inflammatory Immunomodulators Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Autoimmune and Inflammatory Immunomodulators Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Autoimmune and Inflammatory Immunomodulators Sales Market Share by Manufacturer in 2019
Figure 29. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Autoimmune and Inflammatory Immunomodulators Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Autoimmune and Inflammatory Immunomodulators Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Regions (2015-2020)
Figure 36. Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Regions in 2018
Figure 37. North America Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
Figure 38. Europe Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
Figure 40. South America Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020)
Figure 42. North America Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries (2015-2020)
Figure 44. North America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries in 2018
Figure 45. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries in 2018
Figure 47. United States Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries in 2019
Figure 53. Germany Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Regions 2019
Figure 61. China Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries in 2019
Figure 68. South America Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries in 2019
Figure 69. Brazil Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Autoimmune and Inflammatory Immunomodulators Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Autoimmune and Inflammatory Immunomodulators Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Autoimmune and Inflammatory Immunomodulators Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
自己免疫・炎症性免疫調節剤の世界市場（～2026年） Market Analysis and Insights: Global Autoimmune and Inflammatory Immunomodulators Market The global Autoimmune and Inflammatory Immunomodulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autoimmune and Inflammato…- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 自己免疫疾患治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 111090 million by 2025, from USD 101510 million in 2019. The Auto…
- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…